Lv2
170 积分 2023-02-27 加入
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
6小时前
待确认
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
10小时前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
1个月前
已完结
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial
1个月前
已完结
[Guidelines on the management of ascites in cirrhosis (2023 version)]
8个月前
已完结
Morbidity, mortality, cost, and survival estimates of gastrointestinal anastomotic leaks
9个月前
已关闭
肝硬化门静脉高压血流动力学紊乱发生及发展机制
11个月前
已完结
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
11个月前
已完结
新生儿高胆红素血症诊断和治疗专家共识
1年前
已完结
Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials
1年前
已完结
皖公网安备34019202002308
